---
title: AI Hearing Aid Platform Comparison 2026
type: comparison
created: 2026-04-15
updated: 2026-04-21
sources: [oticon-verit-launch-april-2026.md, oticon-play-si-pediatric-launch-april-2026.md, phonak-dnn-noise-reduction-clinical-trial-april-2026.md, starkey-cto-bhowmik-aimbe-april-2026.md, oticon-zeal-ite-launch-aaa-2026.md, starkey-omega-ai-big-ai-awards-2026.md]
related: [../syntheses/hearing-aid-ai-stack-2026.md, ../comparisons/on-device-vs-cloud-ml.md, ../comparisons/otc-vs-prescription-hearing-aids.md, ../entities/sonova-ag.md, ../entities/demant-oticon.md, ../entities/gn-hearing-resound.md, ../syntheses/ai-understanding-gap-hearing-industry.md]
tags: [comparison, platform, 2026, phonak, resound, oticon, signia, starkey, apple, verit, clinical-trial]
---

# AI Hearing Aid Platform Comparison 2026

A platform-by-platform breakdown of the AI capabilities in major hearing aid products as of 2026.

## Platform Comparison Table

| Platform | Chip | Ops/Capacity | Training Data | Key AI Feature | Architecture |
|----------|------|-------------|---------------|---------------|--------------|
| **Phonak Sphere Infinio** | DEEPSONIC (dual-chip) | 7.7B ops/sec | 22M scenes | Spheric Speech Clarity 2.0 | On-device, real-time |
| **ReSound Vivia** | Dedicated DNN chip | 4.9T ops/day | 13.5M sentences | Intelligent Focus | On-device, real-time |
| **Oticon Verit** (Apr 2026) | Sirius (2nd-gen AI) | Not disclosed | Not disclosed | 12dB NR, Auracast, Google Fast Pair, SuddenSound Stabilizer | On-device |
| **Oticon Intent** | Single-chip (Polaris) | Not disclosed | 13M scenes | 4D Sensor (head + body motion) | On-device, DNN 2.0 |
| **Signia Integrated Xperience (IX)** | Integrated (not named) | Not disclosed | Live DNN | Multi-stream RealTime Enhancement + cloud DNN Assistant | Cloud-hybrid |
| **Starkey Genesis AI** | Edge AI (proprietary) | Not disclosed | Not disclosed | Health tracking + fall detection | On-device |
| **Apple AirPods Pro 2** | H2 (Apple silicon) | Not disclosed | Not disclosed | 5-min audiometry, FDA OTC clearance | On-device |

## Key Feature Analysis

### Phonak Sphere Infinio (Sonova)
- **Bet:** Raw processing power via dual-chip DEEPSONIC architecture
- **Spheric Speech Clarity 2.0:** DNN-based enhancement tuned for complex listening environments (restaurants, parties, crowds)
- **Real-time AI:** Yes — one of only two platforms with genuine sample-level AI in the audio path
- **Trade-off:** Larger ITE/BTE form factor to accommodate dual chips; higher power draw
- **Training approach:** 22M annotated acoustic scenes for scene classification and DNN training
- **Market positioning:** Premium; targets active adults in challenging listening environments

### ReSound Vivia (GN Hearing / Amplifon post-acquisition)
- **Bet:** Dedicated neural processing silicon for energy-efficient real-time DNN
- **Intelligent Focus:** AI-driven beamforming that identifies and enhances speech of interest, adapts in real time
- **Real-time AI:** Yes — dedicated DNN chip handles audio processing separate from general DSP
- **4.9T ops/day:** Large aggregate number reflecting continuous DNN inference across all channels throughout a full day of wear
- **Training approach:** 13.5M sentences for speech-specific training
- **Market positioning:** Premium; acquired by Amplifon, distribution through Amplifon network going forward

### Oticon Intent (Demant)
- **Bet:** Sensor fusion — combining audio with inertial sensor data (4D Sensor)
- **4D Sensor:** Tracks head movement and body movement to infer listening intent; e.g., turning to face a speaker signals "focus here"
- **DNN 2.0:** Improved deep neural network vs. prior generation (Oticon Real used DNN 1.0)
- **Real-time AI:** Partial — DNN processes audio but at a lower throughput than Phonak/ReSound dedicated chips
- **13M scenes:** Training data for scene and intent classification
- **Market positioning:** Premium; differentiates on the motion-inference angle rather than raw audio power

### Signia Integrated Xperience / IX (WS Audiology)
- **Bet:** Cloud-hybrid; run a larger effective model by splitting real-time audio (on-device) from personalization (cloud DNN Assistant)
- **Multi-stream RealTime Enhancement:** Simultaneously processes multiple acoustic streams (own voice, conversation partner, background) and enhances each
- **DNN Assistant:** Cloud-hosted model that recommends fitting adjustments based on usage data; delivers personalization without clinic visit
- **Real-time AI:** Partial — on-device handles real-time audio; cloud handles fitting intelligence
- **Privacy trade-off:** Some usage data is transmitted to cloud for DNN Assistant to function
- **Market positioning:** Premium + accessible; also markets Widex Moment (separate brand) with own DNN approach

### Starkey Genesis AI / Omega AI
- **Bet:** Hearing aids as a health platform, not just audio devices
- **Fall detection:** On-device sensor fusion detects falls, sends alerts
- **Health metrics:** Activity tracking, body temperature, heart rate (in some models)
- **Audio AI:** Competent DNN noise reduction, but not the raw-power differentiator Starkey leads with
- **Omega AI (Oct 2025):** Latest flagship with G3 Gen AI Neuro Processor; integrated NPU
- **2026 BIG AI Excellence Awards:** Won two awards — external validation of AI capabilities beyond the audiology industry
- **Market positioning:** Premium; appeals to health-conscious users and family members of older adults

### Apple AirPods Pro 2
- **Bet:** Accessibility and scale — bring hearing aid functionality to the mass market at OTC price
- **FDA clearance:** OTC hearing aid category, 2024; targets mild-to-moderate hearing loss
- **5-minute audiometry:** Built-in hearing test via iPhone; no audiologist required
- **H2 chip:** General-purpose Apple silicon; hearing aid DNN is one of many workloads
- **Price:** $249 — an order of magnitude below prescription hearing aids
- **Limitations:** Not suitable for moderate-severe or severe hearing loss; lacks RIC/BTE form factors; no professional fine-tuning
- **Market positioning:** OTC; competes with Jabra Enhance, Bose SoundControl, Eargo

## Strategic Analysis by Company

### Sonova: Raw Processing Power
Sonova's DEEPSONIC dual-chip bet is a statement that sufficient compute, paired with large-scale training data (22M scenes), can deliver meaningfully better audio outcomes. This is the "brute force + data" strategy — invest in silicon and training data, let the model learn complex acoustics. Risk: power consumption and form factor. Upside: hardest to replicate quickly.

### Demant: Sensor Fusion
Demant's 4D Sensor approach bets that context-aware hearing aids (ones that know where you're looking and how you're moving) will outperform pure audio processing. This reflects a broader research trend — combining audio with multimodal signals rather than just processing harder. Risk: motion data may not be as predictive as hoped. Upside: opens a differentiation axis competitors aren't focused on.

### WS Audiology: Cloud-Hybrid Intelligence + Preference Data
WS Audiology's Signia hybrid approach bets that the fitting and personalization problem is as important as the real-time audio problem — and that cloud compute can solve the fitting problem without compromising latency. Risk: privacy concerns and connectivity dependency. Upside: the cloud model can improve faster than firmware-updated competitors. **April 2026 addition:** WSA launched the Sound Preference Program — a free tool using randomized audio comparisons to classify users as "natural sound" or "enhanced sound" preference (~40% show strong, consistent preference). This structured data collection feeds directly into personalization algorithms and aligns with WSA's dual-brand positioning (Widex natural, Signia enhanced).

### Starkey: Health Ecosystem
Starkey's health platform bet is a hedge against commoditization of audio AI — if all brands converge on similar DNN noise reduction, differentiate on what's connected to the hearing aid. Risk: health features may not influence purchase decisions as much as audio quality. Upside: strong moat if health data becomes valuable for insurance/wellness integrations.

### Apple: Accessibility at Scale (CEO Signal)
Apple's strategy is to define a new category (clinical-grade consumer hearing device) and own it with distribution and ecosystem lock-in. Risk: clinical legitimacy ceiling (not suitable for severe loss). Upside: ~1.5B AirPods users means even 5% with hearing loss represents a massive addressable market untouched by traditional hearing aid brands. **April 2026 signal:** John Ternus — the executive who led AirPods Pro hardware engineering and Apple Silicon — became Apple CEO. The architect of Apple's hearing health hardware is now running the company, reinforcing that hearing health is a strategic priority.

## April 2026 Developments

### Oticon Verit + Play SI
Demant launched two new products with "second-generation AI" — successor to DNN 2.0. Both include Auracast and Google Fast Pair. The Play SI is notable as the first pediatric hearing aid with 4D sensors and Auracast. Full specs of the 2nd-gen AI platform are not yet published.

### Phonak Clinical Trial (NCT07526428)
Sonova registered an interventional clinical trial for DNN noise reduction in moderate-to-severe hearing loss — first of its kind targeting more severe loss with DNN technology. Signals a shift from marketing claims to clinical evidence building.

### Starkey CTO AIMBE Recognition
Starkey's CTO Achin Bhowmik (ex-Intel VP) inducted into AIMBE — validates the health-tech positioning and AI innovation leadership in the hearing aid space.

## What to Watch in 2026–2027

- Will Sonova's DEEPSONIC dual-chip prove out in clinical trial data (NCT07526428) vs. single-chip competitors?
- How does Oticon's "2nd-gen AI" in Verit compare architecturally to DNN 2.0?
- Will Oticon's 4D Sensor become a true differentiator or a marketing feature?
- Will Signia's cloud DNN Assistant drive measurably better satisfaction vs. clinic-only fitting?
- Will Apple expand AirPods hearing aid features to address moderate-severe loss?
- Will any brand achieve genuine federated learning across its user base?
- Will WSA's Sound Preference data create a measurable personalization advantage?
- Will Auracast venue infrastructure reach critical mass?

## Related Pages
- [[hearing-aid-ai-stack-2026]] — Full stack context including silicon and connectivity layers
- [[on-device-vs-cloud-ml]] — Architecture decision framework
- [[otc-vs-prescription-hearing-aids]] — Apple and OTC category context
- [[vertical-integration-trend]] — Ownership and distribution context

## Sources
- Platform specifications from manufacturer product disclosures, 2025–2026
